Company registration number 04092986 (England and Wales)
FINGERPRINT MEDICAL LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024
PAGES FOR FILING WITH REGISTRAR
FINGERPRINT MEDICAL LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 10
FINGERPRINT MEDICAL LIMITED
BALANCE SHEET
AS AT 31 OCTOBER 2024
31 October 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
4
1,610,056
1,679,934
Tangible assets
5
7,031
33,553
1,617,087
1,713,487
Current assets
Stocks
44,605
39,830
Debtors
6
2,602,045
1,806,132
Cash at bank and in hand
743,376
855,869
3,390,026
2,701,831
Creditors: amounts falling due within one year
7
(2,512,087)
(1,574,948)
Net current assets
877,939
1,126,883
Total assets less current liabilities
2,495,026
2,840,370
Provisions for liabilities
8
(330,000)
(430,000)
Net assets
2,165,026
2,410,370
Capital and reserves
Called up share capital
75
75
Capital redemption reserve
25
25
Profit and loss reserves
2,164,926
2,410,270
Total equity
2,165,026
2,410,370

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 8 September 2025
Mr G Cooper
Director
Company Registration No. 04092986
FINGERPRINT MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024
- 2 -
1
Accounting policies
Company information

Fingerprint Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is 14 Brooks Mews, Brooks Mews, London, United Kingdom, W1K 4DG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Reporting period

The previous reporting period was shortened by 3 months so as to be coterminous with the year end of its parent company. As a result, the comparative period within these financial statements are presented for the 9 month period ending 31 October 2024, and are therefore not entirely comparable.

1.4
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recover ed.

1.5
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

FINGERPRINT MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
1
Accounting policies
(Continued)
- 3 -
1.6
Intangible fixed assets other than goodwill

Intangible assets are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets comprise computer software costs on internally generated intangibles. Identifiable costs are capitalised to the extent that the technical, commercial and financial feasibility of the development can be demonstrated.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Other intangible assets
10% straight line method
1.7
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery etc
25% - 33% straight line method

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.8
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

FINGERPRINT MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
1
Accounting policies
(Continued)
- 4 -
1.9
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.10
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.11
Financial instruments

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.12
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

FINGERPRINT MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
1
Accounting policies
(Continued)
- 5 -
1.13
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.14
Provisions

Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision i s measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

1.15
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.16
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.17
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

FINGERPRINT MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
1
Accounting policies
(Continued)
- 6 -
1.18
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

1.19

Related party exemption

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Amortisation of intangibles

The annual amortisation charge for intangible assets is sensitive to changes in relation to the value of works performed on software as these assets relate to capitalised staff costs. The useful economic life is assessed annually and is amended as necessary based on the value of the work the intangible assets relate to.

The directors have made key assumptions regarding the useful life of intangible assets and have determined t hat it has a useful life of 10 years. The 10 year period is considered appropriate to match the anticipated future profitability arising from th e associated software developed and from continued future growth within the trade of the group.

The company previously applied a useful life of 20 years to intangible assets, with this re-assessed to 10 years during the prior period.

Capitalisation of software costs

Staff time is incurred in developing software assets. This is then capitalised as the income this will generate is spread over the life of the associated product and service line. The amount of staff cost capitalised is based upon estimate of time incurred in these areas of work and is reviewed annually. This is a subjective area due to estimates of time, as well as nature of internally generated intangible assets.

FINGERPRINT MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
- 7 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
19
17
4
Intangible fixed assets
Other
£
Cost
At 1 November 2023
2,354,909
Additions
311,162
At 31 October 2024
2,666,071
Amortisation and impairment
At 1 November 2023
674,975
Amortisation charged for the year
381,040
At 31 October 2024
1,056,015
Carrying amount
At 31 October 2024
1,610,056
At 31 October 2023
1,679,934

The total carrying amount of all assets is pledged as security for the bank borrowings of a fellow group entity under a fixed and floating charge.

FINGERPRINT MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
- 8 -
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 November 2023
101,006
Additions
2,375
Disposals
(59,400)
At 31 October 2024
43,981
Depreciation and impairment
At 1 November 2023
67,453
Depreciation charged in the year
12,341
Eliminated in respect of disposals
(42,844)
At 31 October 2024
36,950
Carrying amount
At 31 October 2024
7,031
At 31 October 2023
33,553

The total carrying amount of all assets is pledged as security for the bank borrowings of a fellow group entity under a fixed and floating charge.

6
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
170,053
168,293
Amounts owed by group undertakings
2,410,683
1,594,958
Other debtors
21,309
42,881
2,602,045
1,806,132

The total carrying amount of all assets is pledged as security for the bank borrowings of a fellow group entity under a fixed and floating charge.

Amounts owed by group undertakings are interest free, unsecured and repayable on demand.

FINGERPRINT MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
- 9 -
7
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
58,092
52,015
Amounts owed to group undertakings
458,263
458,263
Corporation tax
120,069
148,453
Other taxation and social security
84,148
40,984
Other creditors
1,791,515
875,233
2,512,087
1,574,948

Amounts owed to group undertakings are interest free, unsecured and repayable on demand.

8
Provisions for liabilities
2024
2023
£
£
Deferred tax liabilities
9
330,000
430,000
9
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2024
2023
Balances:
£
£
Accelerated capital allowances
1,758
10,000
Tax losses
(72,000)
-
Other timing differences
400,242
420,000
330,000
430,000
2024
Movements in the year:
£
Liability at 1 November 2023
430,000
Credit to profit or loss
(100,000)
Liability at 31 October 2024
330,000

The deferred tax liability set out above is not expected to reverse within 12 months.

FINGERPRINT MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
- 10 -
10
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report was unqualified.

Senior Statutory Auditor:
Steve Burke
Statutory Auditor:
Azets Audit Services
11
Financial commitments, guarantees and contingent liabilities

As at 31 October 2024 the company had total guarantees and commitments of £1,858,774 (31 October 2023: £1,997,759) in respect of group companies and £Nil (31 October 2023: £509) in respect of operating lease commitments.

12
Parent company

Aliter Capital II LLP is the company's ultimate controlling party, a limited liability partnership whose registered office is 14 Brook's Mews, London, W1K 4DG.

The smallest group of which the company is a member and for which group accounts are prepared is headed up by Athera Healthcare Limited (previously Halcyon (Bidco) Limited), whose registered address is 14 Brook's Mews, London, W1K 4DG. The immediate parent company is Fingerprint Global Limited.

The largest group of which the company is a member and for which group accounts are prepared is headed up by Athera Healthcare Group Limited (formerly Halcyon Group (Holdings) Limited), whose registered address is 14 Brook's Mews, London, W1K 4DG.

2024-10-31 2023-11-01 false false false 17 September 2025 CCH Software CCH Accounts Production 2025.100 No description of principal activity Mr G Cooper 04092986 2023-11-01 2024-10-31 04092986 2024-10-31 04092986 2023-10-31 04092986 core:IntangibleAssetsOtherThanGoodwill 2024-10-31 04092986 core:IntangibleAssetsOtherThanGoodwill 2023-10-31 04092986 core:OtherPropertyPlantEquipment 2024-10-31 04092986 core:OtherPropertyPlantEquipment 2023-10-31 04092986 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 04092986 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 04092986 core:CurrentFinancialInstruments 2024-10-31 04092986 core:CurrentFinancialInstruments 2023-10-31 04092986 core:ShareCapital 2024-10-31 04092986 core:ShareCapital 2023-10-31 04092986 core:CapitalRedemptionReserve 2024-10-31 04092986 core:CapitalRedemptionReserve 2023-10-31 04092986 core:RetainedEarningsAccumulatedLosses 2024-10-31 04092986 core:RetainedEarningsAccumulatedLosses 2023-10-31 04092986 bus:Director1 2023-11-01 2024-10-31 04092986 core:IntangibleAssetsOtherThanGoodwill 2023-11-01 2024-10-31 04092986 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2023-11-01 2024-10-31 04092986 core:PlantMachinery 2023-11-01 2024-10-31 04092986 2023-02-01 2023-10-31 04092986 core:IntangibleAssetsOtherThanGoodwill 2023-10-31 04092986 core:OtherPropertyPlantEquipment 2023-10-31 04092986 core:OtherPropertyPlantEquipment 2023-11-01 2024-10-31 04092986 core:WithinOneYear 2024-10-31 04092986 core:WithinOneYear 2023-10-31 04092986 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 04092986 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 04092986 bus:FRS102 2023-11-01 2024-10-31 04092986 bus:Audited 2023-11-01 2024-10-31 04092986 bus:FullAccounts 2023-11-01 2024-10-31 xbrli:pure xbrli:shares iso4217:GBP